Compounded tirzepatide
Sold by Fifty 410 · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$133
| Medication · Starter Program, 3-month | $133 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Starter Program, 3-month “Starter Program Tirzepatide $133 /month $399 total” | Per month$133 | Charged today$399 |
| Mid Dose Program, 3-month “Mid Dose Program $166 /month $499 total” | Per month$166 | Charged today$499 |
| High Dose Program, 3-month “High Dose Program $183 /month $549 total” | Per month$183 | Charged today$549 |
We earn nothing from this link. Fifty 410 has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Both |
|---|---|
| Cancellation | “Once compounding begins, your medication is prepared to your prescribed specifications. This patient-specific preparation is why routine cancellations and refunds are not available after the compounding process starts.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from fifty410.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Explicitly no membership fee: 'There is no membership fee' and 'When am I charged? Only if a provider issues a prescription... There is no membership fee.' Both products are described only as 'administered by subcutaneous injection' without ever specifying vial vs. pen, so form is not-disclosed rather than assumed.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.